Related Experiment Video
Updated: Jan 25, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
Yingru Zhi1, Mubalake Abudoureyimu1, Hao Zhou2
1Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, People's Republic of China.
Abstract:
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide. Indeed, despite the benefit of sorafenib in the treatment of some patients with HCC, the majority of these patients have a poor response to or intolerance of sorafenib, resulting in further tumor progression. Exploring the mechanisms underlying sorafenib resistance is essential to the treatment of HCC. Long noncoding RNAs (lncRNAs) are known as participants in tumorigenesis. In this study, we identified that long intergenic non-protein coding RNA, regulator of reprogramming (LINC-ROR), was upregulated in HCC cell lines, which was transcriptionally activated by FOXM1. Furthermore, the sponging of miR-876-5p by LINC-ROR released FOXM1, thereby forming a positive-feedback loop. Additionally, we demonstrated that upregulation of both FOXM1 and LINC-ROR impaired the sensitivity to sorafenib in HCC cells. The role of this feedback loop was demonstrated by rescue assays. These results revealed a novel molecular feedback loop between LINC-ROR and FOXM1 and elucidated their functions in sorafenib sensitivity of HCC cell lines.
Insights
This study reveals a new feedback loop involving LINC-ROR and FOXM1 in hepatocellular carcinoma (HCC). This loop promotes resistance to sorafenib, a key treatment for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major global cause of cancer death.
- Sorafenib is a vital treatment for HCC, but many patients exhibit poor response or intolerance.
- Understanding sorafenib resistance mechanisms is crucial for improving HCC treatment outcomes.
Purpose of the Study:
- To investigate the role of long noncoding RNAs (lncRNAs) in HCC sorafenib resistance.
- To identify the molecular mechanisms underlying sorafenib resistance in hepatocellular carcinoma.
- To elucidate the functional relationship between LINC-ROR, FOXM1, and sorafenib sensitivity in HCC.
Main Methods:
- Investigated the expression of LINC-ROR in HCC cell lines.
- Determined the transcriptional activation of LINC-ROR by FOXM1.
- Analyzed the interaction between LINC-ROR, miR-876-5p, and FOXM1 using sponging assays.
- Assessed the impact of LINC-ROR and FOXM1 upregulation on sorafenib sensitivity in HCC cells.
- Performed rescue assays to validate the feedback loop's role.
Main Results:
- LINC-ROR was found to be upregulated in HCC cell lines.
- FOXM1 was identified as a transcriptional activator of LINC-ROR.
- A positive-feedback loop was established where LINC-ROR sponges miR-876-5p, releasing FOXM1.
- Upregulation of both FOXM1 and LINC-ROR significantly reduced HCC cell sensitivity to sorafenib.
- Rescue assays confirmed the critical role of this feedback loop in sorafenib resistance.
Conclusions:
- A novel molecular feedback loop between LINC-ROR and FOXM1 was identified in HCC.
- This LINC-ROR/FOXM1 feedback loop plays a significant role in mediating sorafenib resistance in hepatocellular carcinoma.
- Targeting this pathway may offer a potential therapeutic strategy for overcoming sorafenib resistance in HCC patients.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...
Master Transcription Regulators

